Swiss dental company vVardis has raised $50 million to help refinance debt and expand sales of Curodont, a noninvasive treatment for early tooth decay.
Curodont uses a biomimetic formula that repairs enamel using minerals from saliva, offering an alternative to drilling and filling, according to the company.
